Do you want to publish a course? Click here

Objective: Febrile seizures are the most common seizures in children less than 5 years(2-5%),and the risk of its recurrence is 50%(>1year),30%(<1year).We focused on the effect and safety of the prophylaxis treatment of recurrent FS beacuase it is a terrifying case for the parents. Materials&Methods:This is a trial study on 40 patient with FS.Clonazepam was recommended 0.05mg/kg/d then anti e when fever exceed 38°.We did follow up every 3 month during one year. Results:we followed 35 patient, familial history of FS found in 57.1%,a history of epilepsy in 28.57%.clonazepam side effects were supportable the most common was lawson 14.28%,the efficacy of the treatment we didn’t noticed any episode of FS during the study 97.1%. Conclusion: Clonazepam is a safe and effective and easy treatement for the parents for the prophylaxis of FS recurrence.
This paper presents a new solution that allows the doctors to know drug interactions, considering other affecting factors such as the patient's age, weight, physiological and pathological condition. This solution is characterized by being increment al, not only by enriching the database with drug interactions information, but also by its ability to conclude other interactions through a built-in expert system. The system concludes drugs interactions based on its active substrates and the potential interactions between them or between the drugs families. The system serves in three ways; it determines whether the patient illness is possibly due to the medications he is on. It alerts the doctor to the interaction of the newly prescribed medication with the patient’s medications, and to its influence on the patient’s physiological or pathological condition. Besides, it suggests alternative drugs when needed. The solution offers additional services such as binding between the brand name and the generic drug, and between drugs and diseases.
mircosoft-partner

هل ترغب بارسال اشعارات عن اخر التحديثات في شمرا-اكاديميا